Mucin 5B Promoter Polymorphism Is Associated with Susceptibility to Interstitial Lung Diseases in Chinese Males
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mucin 5B Promoter Polymorphism Is Associated with Susceptibility to Interstitial Lung Diseases in Chinese Males
Authors
Keywords
Pulmonary fibrosis, Pneumonia, Interstitial lung diseases, Polymerase chain reaction, Alleles, Autoimmune diseases, Smoking habits, Genotyping
Journal
PLoS One
Volume 9, Issue 8, Pages e104919
Publisher
Public Library of Science (PLoS)
Online
2014-08-15
DOI
10.1371/journal.pone.0104919
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of smoking, gender and occupational exposure on the risk of severe pulmonary fibrosis: a population-based case-control study
- (2014) Magnus Ekström et al. BMJ Open
- Decennial trends of social differences in smoking habits in Italy: a 30-year update
- (2013) Giuseppe Gorini et al. CANCER CAUSES & CONTROL
- Association of the SNP rs1800925(C/T) in the Interleukin-13 Gene Promoter with Pulmonary Function in Chinese Han Patients with Idiopathic Pulmonary Fibrosis
- (2013) Ming Ding et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- TGF-β1 T869C Polymorphism May Affect Susceptibility to Idiopathic Pulmonary Fibrosis and Disease Severity
- (2013) Ji Young Son et al. LUNG
- Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis
- (2013) Tasha E Fingerlin et al. NATURE GENETICS
- The Idiopathic Pulmonary Fibrosis Honeycomb Cyst Contains A Mucocilary Pseudostratified Epithelium
- (2013) Max A. Seibold et al. PLoS One
- The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population
- (2013) Raphael Borie et al. PLoS One
- Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis
- (2013) Carmel J Stock et al. THORAX
- Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study
- (2013) Imre Noth et al. Lancet Respiratory Medicine
- Epidemiology of idiopathic pulmonary fibrosis
- (2013) Brett Ley et al. Clinical Epidemiology
- The Pulmonary Fibrosis-Associated MUC5B Promoter Polymorphism Does Not Influence the Development of Interstitial Pneumonia in Systemic Sclerosis
- (2012) Anna L. Peljto et al. CHEST
- Mucin5B expression by lung alveolar macrophages is increased in long-term smokers
- (2012) Ruth Sepper et al. JOURNAL OF LEUKOCYTE BIOLOGY
- HLA-A and HLA-B gene polymorphism and idiopathic pulmonary fibrosis in a Han Chinese population
- (2012) Ji Zhang et al. RESPIRATORY MEDICINE
- Idiopathic pulmonary fibrosis in Taiwan – A population-based study
- (2012) Chih-Cheng Lai et al. RESPIRATORY MEDICINE
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Genetic Interstitial Lung Disease
- (2011) Megan Stuebner Devine et al. CLINICS IN CHEST MEDICINE
- A Variant in the Promoter ofMUC5Band Idiopathic Pulmonary Fibrosis
- (2011) Yingze Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- A CommonMUC5BPromoter Polymorphism and Pulmonary Fibrosis
- (2011) Max A. Seibold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ectopic respiratory epithelial cell differentiation in bronchiolised distal airspaces in idiopathic pulmonary fibrosis
- (2011) L. Plantier et al. THORAX
- MUC5B Is the Major Mucin in the Gel Phase of Sputum in Chronic Obstructive Pulmonary Disease
- (2008) Sara Kirkham et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started